Condition: Cancer of Unknown Primary · Sponsor: Erasmus Medical Center
The investigators will determine the proportion of CUP patients in whom the primary tumor can be identified by \[18F\]F-FAPI PET-CT.
This description comes directly from the study's public registry record.
Sophie Veldhuijzen van Zanten, MD, PhD · 0107042006 · fapiforcup@erasmusmc.nl
Esther Droogers · 0107042006 · e.droogers@erasmusmc.nl
Always discuss trial participation with your own doctor first.
| Antoni van Leeuwenhoekziekenhuis | Amsterdam, Netherlands | Recruiting |
| UMC Groningen | Groningen, Netherlands | Recruiting |
| Maastricht UMC | Maastricht, Netherlands | Recruiting |
| Radboud UMC | Nijmegen, Netherlands | Recruiting |
| Erasmus Medical Center | Rotterdam, Netherlands | Recruiting |
| UMC Utrecht | Utrecht, Netherlands | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06644716